Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 1/20 | 0.32 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6363602 | 0.71 | — | — | |
| SCHEMBL8434912 | 0.71 | — | — | |
| SCHEMBL8074334 | 0.69 | ALDH1A1 (0.41) | CYP4F2CYP4A11TDP1ALDH1A1FFAR3 | |
| SCHEMBL173322 | 0.69 | FFAR3 (0.41) | CYP4F2CYP4A11TDP1ALDH1A1FFAR3 | |
| SCHEMBL899422 | 0.69 | TDP1 (0.33) | CYP4F2CYP4A11TDP1ALDH1A1FFAR3 | |
| SCHEMBL6449919 | 0.67 | TET2 (0.34) | FFAR3TSHR | |
| SCHEMBL7869640 | 0.67 | — | — | |
| SCHEMBL9142384 | 0.67 | CYP4F2 (0.38) | CYP4F2CYP4A11 | |
| SCHEMBL6764293 | 0.67 | TSHR (0.43) | TDP1ALDH1A1TSHR | |
| SCHEMBL6847171 | 0.67 | ALDH1A1 (0.39) | CYP4F2CYP4A11TDP1ALDH1A1FFAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6849384-B2 | Photoacid generators, photoresist compositions containing the same and pattering method with the use of the compositions | NEC CORPORATION (JP) | 2005-02-01 | — | — | US | disclosed |
| US-6638685-B2 | Resolution, sensitivity and smoothness on side surfaces of a transferred pattern; photolithography | NEC CORPORATION (JP) | 2003-10-28 | — | — | US | disclosed |
| US-20030198889-A1 | Photoacid generators, photoresist compositions containing the same and pattering method with the use of the compositions | NEC CORPORATION (JP) | 2003-10-23 | — | — | US | disclosed |
| US-6602647-B2 | Photo acid generator with high transparency and excellent heat stability in a photoresist for lithography using far ultraviolet light, especially light of ArF excimer consists of a cyclic sulfonium compound with 2-oxo group | NEC CORPORATION (JP) | 2003-08-05 | — | — | US | disclosed |
| US-20020182535-A1 | Photoacid generator containing two kinds of sulfonium salt compound, chemically amplified resist containing the same and pattern transfer method | NEC CORPORATION (JP) | 2002-12-05 | — | — | US | disclosed |
| US-20020045122-A1 | Sulfonium salt compound and resist composition and pattern forming method using the same | NEC CORPORATION | 2002-04-18 | — | — | US | disclosed |
| EP-1113334-A1 | Sulfonium salt compound, resist composition comprising the same and pattern forming method using the composition | NEC CORPORATION (JP) | 2001-07-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030198889-A1 | Photoacid generators, photoresist compositions containing the same and pattering method with the use of the compositions | PPOX, SULT1A1, TST | CYP4F2 1392/4885CYP4A11 1556/4885TDP1 3934/4885 |
| US-20020182535-A1 | Photoacid generator containing two kinds of sulfonium salt compound, chemically amplified resist containing the same and pattern transfer method | ASIC1, ASIC3, SULT1A1 | CYP4F2 4229/4885CYP4A11 3431/4885TDP1 2782/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.